Show simple item record

dc.contributor.authorYelland, Michael
dc.date.accessioned2021-07-21T06:18:21Z
dc.date.available2021-07-21T06:18:21Z
dc.date.issued2017
dc.identifier.issn0003-4819en_US
dc.identifier.doi10.7326/ACPJC-2017-166-2-002en_US
dc.identifier.urihttp://hdl.handle.net/10072/406199
dc.languageEnglishen_US
dc.publisherAmerican College of Physiciansen_US
dc.relation.ispartofpagefromJC2en_US
dc.relation.ispartofissue2en_US
dc.relation.ispartofjournalAnnals of Internal Medicineen_US
dc.relation.ispartofvolume166en_US
dc.subject.fieldofresearchMedical and Health Sciencesen_US
dc.subject.fieldofresearchcode11en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsMedicine, General & Internalen_US
dc.subject.keywordsGeneral & Internal Medicineen_US
dc.subject.keywordsDULOXETINEen_US
dc.titlePregabalin reduces fibromyalgia pain but increases adverse events (Review)en_US
dc.typeJournal articleen_US
dc.type.descriptionC2 - Articles (Other)en_US
dcterms.bibliographicCitationYelland, M, Pregabalin reduces fibromyalgia pain but increases adverse events (Review), Annals of Internal Medicine, 2017, 166 (2), pp. JC2en_US
dc.date.updated2021-07-21T06:15:38Z
gro.hasfulltextNo Full Text
gro.griffith.authorYelland, Michael


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record